CBRE Group, Inc. is slated to report first-quarter 2017 results on Apr 27, before the market opens. Last quarter, this commercial real estate services and investment firm delivered a 17.72% positive earnings surprise.
CBRE beat estimates in all of the trailing four quarters, with a positive average surprise of 8.24%.
Shares of the company gained 14.5% in the last three months. The Zacks Consensus Estimate for first-quarter earnings per share is currently pegged at 34 cents.
The graph below depicts this surprise history.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
CBRE Group, Inc. is slated to report first-quarter 2017 results on Apr 27, before the market opens. Last quarter, this commercial real estate services and investment firm delivered a 17.72% positive earnings surprise.
CBRE beat estimates in all of the trailing four quarters, with a positive average surprise of 8.24%.
Shares of the company gained 14.5% in the last three months. The Zacks Consensus Estimate for first-quarter earnings per share is currently pegged at 34 cents.
The graph below depicts this surprise history.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on EPR - FREE
Get the latest research report on DOC - FREE